We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
US Foods
USFD
$21.4B
| $1.2M | 0.02% |
37,561
-167,820
| -82% | -$4.75M |
|
752
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
| $1.2M | 0.02% |
29,430
+20,147
| +217% | +$829K |
|
753
W.R. Berkley
WRB
$28B
| $1.2M | 0.02% |
56,413
-104,251
| -65% | -$2.13M |
|
|
CAA
754
DELISTED
CalAtlantic Group, Inc.
CAA
| $1.19M | 0.02% |
21,107
-6,890
| -25% | -$336K |
|
|
CNR
755
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.19M | 0.02% |
+61,600
| New | +$1.04M |
|
756
Brookdale Senior Living
BKD
$3.62B
| $1.19M | 0.02% |
122,460
+106,388
| +662% | +$1.08M |
|
757
Sarepta Therapeutics
SRPT
$1.66B
| $1.18M | 0.02% |
21,198
-12,348
| -37% | -$654K |
|
758
Regenxbio
RGNX
$623M
| $1.18M | 0.02% |
+35,421
| New | +$1.07M |
|
759
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.36B
| $1.17M | 0.02% |
+85,400
| New | +$1.17M |
|
760
Unifirst Corp
UNF
$5.32B
| $1.17M | 0.02% |
+7,118
| New | +$1.13M |
|
761
Adeia
ADEA
$2.86B
| $1.17M | 0.02% |
181,724
+147,670
| +434% | +$867K |
|
762
Box
BOX
$4.02B
| $1.17M | 0.02% |
55,518
-160,548
| -74% | -$3.39M |
|
763
MarineMax
HZO
$800M
| $1.17M | 0.02% |
+62,063
| New | +$1.2M |
|
764
Brown & Brown
BRO
$22.9B
| $1.17M | 0.02% |
+45,424
| New | +$1.14M |
|
765
Labcorp
LH
$24.3B
| $1.17M | 0.02% |
8,510
-27,503
| -76% | -$3.63M |
|
766
Choice Hotels
CHH
$5.03B
| $1.16M | 0.02% |
14,965
+10,278
| +219% | +$751K |
|
767
Albemarle
ALB
$13.5B
| $1.16M | 0.02% |
+9,051
| New | +$1.23M |
|
768
Biogen
BIIB
$29.9B
| $1.16M | 0.02% |
3,632
-4,369
| -55% | -$1.4M |
|
769
Century Aluminum
CENX
$4.57B
| $1.16M | 0.02% |
+58,835
| New | +$901K |
|
770
Marriott International
MAR
$98.7B
| $1.15M | 0.02% |
+8,500
| New | +$1.04M |
|
|
RVNC
771
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.15M | 0.02% |
+32,191
| New | +$925K |
|
772
Cytokinetics
CYTK
$11B
| $1.14M | 0.02% |
139,925
+68,754
| +97% | +$781K |
|
773
Children's Place
PLCE
$53.6M
| $1.13M | 0.02% |
7,796
-29,554
| -79% | -$3.6M |
|
|
AFAM
774
DELISTED
Almost Family Inc
AFAM
| $1.13M | 0.02% |
+20,461
| New | +$1.09M |
|
|
LADR
775
Ladder Capital
LADR
$1.25B
| $1.13M | 0.02% |
+83,012
| New | +$1.14M |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.